Aytu BioScience Correlations
AYTU Stock | USD 1.62 0.02 1.25% |
The current 90-days correlation between Aytu BioScience and Aquestive Therapeutics is 0.13 (i.e., Average diversification). The correlation of Aytu BioScience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Aytu BioScience Correlation With Market
Significant diversification
The correlation between Aytu BioScience and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aytu BioScience and DJI in the same portfolio, assuming nothing else is changed.
Aytu |
Moving together with Aytu Stock
0.77 | VALN | Valneva SE ADR | PairCorr |
0.7 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.87 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.9 | LLY | Eli Lilly Sell-off Trend | PairCorr |
0.92 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.88 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.75 | SXTPW | 60 Degrees Pharmaceu | PairCorr |
0.66 | BIAFW | BioAffinity Technologies | PairCorr |
0.7 | MREO | Mereo BioPharma Group | PairCorr |
0.87 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
0.62 | PDSB | PDS Biotechnology Corp | PairCorr |
0.94 | PEPG | PepGen | PairCorr |
0.79 | ADAP | Adaptimmune Therapeutics | PairCorr |
0.81 | AMGN | Amgen Inc | PairCorr |
0.67 | ANEB | Anebulo Pharmaceuticals | PairCorr |
Moving against Aytu Stock
0.89 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.85 | NAMS | NewAmsterdam Pharma | PairCorr |
0.77 | GILD | Gilead Sciences | PairCorr |
0.66 | PMVP | Pmv Pharmaceuticals | PairCorr |
0.54 | PHVS | Pharvaris BV | PairCorr |
0.47 | LPCN | Lipocine | PairCorr |
0.43 | ESLAW | Estrella Immunopharma | PairCorr |
0.42 | PLRX | Pliant Therapeutics | PairCorr |
0.9 | AVTE | Aerovate Therapeutics | PairCorr |
0.88 | CDXS | Codexis | PairCorr |
0.88 | VREX | Varex Imaging Corp | PairCorr |
0.87 | SGMO | Sangamo Therapeutics Buyout Trend | PairCorr |
0.85 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.76 | AGIO | Agios Pharm | PairCorr |
0.38 | CMND | Clearmind Medicine Common | PairCorr |
0.36 | ANTX | AN2 Therapeutics | PairCorr |
0.36 | SYRE | Spyre Therapeutics Symbol Change | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Aytu Stock performing well and Aytu BioScience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aytu BioScience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
AQST | 3.34 | 0.00 | 0.02 | 0.12 | 3.80 | 6.51 | 20.28 | |||
EVOK | 3.85 | (0.07) | (0.01) | 0.07 | 4.66 | 6.20 | 48.38 | |||
ADMP | 4.75 | (1.74) | 0.00 | 5.66 | 0.00 | 8.72 | 40.76 | |||
GHSI | 5.47 | 0.68 | 0.06 | (11.49) | 8.11 | 18.66 | 101.05 | |||
ACRX | 4.72 | 0.62 | 0.09 | (0.90) | 4.26 | 13.85 | 29.52 | |||
SGIOY | 0.90 | (0.15) | 0.00 | (3.07) | 0.00 | 1.63 | 5.10 | |||
SBFM | 3.06 | 0.05 | 0.01 | 0.17 | 3.59 | 6.97 | 19.65 | |||
ALIM | 2.74 | 1.54 | 0.64 | (0.59) | 0.37 | 3.28 | 82.36 | |||
SXTC | 5.02 | (0.93) | 0.00 | 3.42 | 0.00 | 11.29 | 29.79 | |||
SHPH | 5.39 | (1.23) | 0.00 | 4.27 | 0.00 | 10.08 | 50.96 |
Aytu BioScience Corporate Management
Russ McMahen | Senior Development | Profile | |
Christopher Brooke | Chief Officer | Profile | |
Margaret Cabano | Vice Operations | Profile | |
Topher Brooke | Chief Officer | Profile | |
Greg Pyszczymuka | Chief Officer | Profile |